|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/20/20 AbCellera Biologics Inc. S-1 15:8.3M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size
1: S-1 Registration Statement (General Form) HTML 1.96M
2: EX-2.1 Plan of Acquisition, Reorganization, Arrangement, HTML 354K
Liquidation or Succession
3: EX-3.2 Articles of Incorporation/Organization or Bylaws HTML 313K
4: EX-4.1 Instrument Defining the Rights of Security Holders HTML 175K
5: EX-10.1 Material Contract HTML 272K
6: EX-10.2 Material Contract HTML 186K
7: EX-10.3 Material Contract HTML 103K
8: EX-10.4 Material Contract HTML 131K
9: EX-10.5 Material Contract HTML 39K
10: EX-10.6 Material Contract HTML 149K
11: EX-10.7 Material Contract HTML 152K
12: EX-21.1 Subsidiaries List HTML 8K
13: EX-23.1 Consent of Expert or Counsel HTML 7K
14: EX-23.2 Consent of Expert or Counsel HTML 7K
15: EX-99.1 Miscellaneous Exhibit HTML 7K
| EX-99.1 |
Exhibit 99.1
Consent of Director Nominee
AbCellera Biologics Inc. is filing a Registration Statement on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), in connection with the initial public offering of its common shares. In connection therewith, I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of directors of AbCellera Biologics Inc. in the Registration Statement, as may be amended from time to time. I also consent to the filing of this consent as an exhibit to such Registration Statement and any amendments thereto.
| Name: | John Edward Hamer, Ph.D. | |
| Date: | November 20, 2020 | |
| This ‘S-1’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 11/20/20 | CORRESP, DRS, DRS/A, UPLOAD | ||
| List all Filings | ||||